BIO-PATH HOLDINGS, INC.
corporate_fare Company Profile
BIO-PATH HOLDINGS, INC. (OTC:BPTH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for BPTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-16, rated 9/10. Across its 7 most recent items scored 7 or higher, the top rating is 10/10, with 7 rated 8 or above. Recent SEC coverage for BPTH spans 8-K, 10-Q, 1-Z.
Recent high-impact activity:
- Bio-Path Holdings Pivots to Crypto, Creates New Preferred Stock, and Restarts AML Trials
- Distressed Biotech Pivots to Crypto, Secures Potential $10M Judgment, Cancels Reverse Split
- BIO-PATH Holdings Discloses Going Concern, Ineffective Controls, and Massive Dilution to CEO's Advisory Firm
- Bio-Path Holdings Amends Charter for New Preferred Stock with 51% Voting Power, Appoints Scientific Advisors
- BIO-PATH Holdings Fails to Sell Any Shares in Regulation A Offering, Securing Zero Proceeds
Financial Snapshot
Short Interest & Short Volume
1.86 days to coverFINRA reported short interest of 2,365 shares in BPTH as of the October 30, 2026 settlement, unchanged from the prior period — about 1.9 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.